Perfil
Esper Boel is currently a Director at MonTa Biosciences ApS.
Prior to this, he held positions as Head-Biotechnology Unit at Novo Nordisk A and Senior Vice President & Head-Discovery at Symphogen A. Boel received his undergraduate and doctorate degrees from the University of Aarhus in 1979.
Cargos activos de Esper Boel
| Empresas | Cargo | Inicio |
|---|---|---|
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Esper Boel.
| Empresas | Cargo | Fin |
|---|---|---|
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Director Técnico/Científico/I+D | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formación de Esper Boel.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Aarhus
University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Health Technology |
- Bolsa de valores
- Insiders
- Esper Boel
















